TERT and glioma: Briefly, our research offers comprehensive epidemiological evidence that common variants in the TERT-CLPTM1L region show association with predisposition of glioma, myeloproliferative neoplasms, idiopathic pulmonary fibrosis, esophageal cancer, gastric cancer, skin cancer, bladder cancer, lung cancer, and pancreatic cancer.